Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_assertion type Assertion NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_head.
- NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_assertion description "[Overall, the XRCC1 homozygous variant gln399gln genotype was related to a significantly reduced risk of both basal cell [BCC; odds ratio (OR) 0.7, 95% confidence interval 0.4-1.0] and squamous cell carcinoma (SCC; OR 0.6, 95% confidence interval 0.3-0.9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_provenance.
- NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_assertion evidence source_evidence_literature NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_provenance.
- NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_assertion SIO_000772 11782372 NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_provenance.
- NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_assertion wasDerivedFrom befree-2016 NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_provenance.
- NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_assertion wasGeneratedBy ECO_0000203 NP341559.RA4420DriPcw_3xRMvdz4wiUWCWQ8K6rzcQ6pCKEkPebI130_provenance.